Medication reference
Terlipressin
Monograph awaiting updateThis monograph will be updated in the future.
No original site article was mapped to this record. The available historical structured fields and official-source links are retained.
Historical first look: uses, mechanism, dosing context, and administration
Recovered v5.1 source content; historical, awaiting current review.
- Id
- terlipressin
Source ID
H51-7684F288397EC9C36BDEACEA - Generic name
- Terlipressin
Source ID
H51-66C278E93827A1FA89B48900 - Class
- Cardiovascular and vasoactive
Source ID
H51-461C0D83C5131C1A0E26142E - Subclass
- Vasopressin analog
Source ID
H51-4D8FBE049AF3764451503C4B - Primary uses
- Hepatorenal syndrome with rapid reduction in kidney function in adults
Source ID
H51-3FE119111CE53167235A913F
- Hepatorenal syndrome with rapid reduction in kidney function in adults
- Mechanism
- A vasopressin analog whose active metabolites predominantly stimulate V1 receptors and cause vasoconstriction.
Source ID
H51-89266BFF5D89195724B204C5 - Mechanism level
- drug_specific
Source ID
H51-A8B083AF63A22B0557BA478E - Basic dosing orientation
- Adult | Existing preparation record; use current package insert for indication-specific selection | Label dose schedule adjusted by serum creatinine response | Not normalized in the preparation record | See current package insert and professional guidance | IV infusion; Adult | Label-scheduled dose | Label-scheduled dose | Patient- and indication-specific | See current package insert | IV push
Source ID
H51-1D266D78DF3E7091E40A2CBE - Administration orientation
- Slow IV bolus over approximately 2 minutes; Over about 2 minutes; Reconstituted product concentration; Over about 2 minutes
Source ID
H51-8CB966CC4CA97F32AB4155C9 - Renal and population orientation
- Separate renal reference: Open Renal Dosing Master (opens in a new tab)The existing monograph contains a renal or nephrotoxicity signal; verify exact adjustment and monitoring in the current label.
Source ID
H51-2CD4DEF3A54D49DCB30189B0 - Key safety orientation
- Serious or fatal respiratory failure.
Source ID
H51-4ECCD182972171DA1E36B519 - Ischemic events and contraindication in hypoxia or worsening respiratory symptoms.
Source ID
H51-880F20825D569FA9CEF70712 - Avoid in patients unlikely to benefit such as very high creatinine or ACLF grade 3 per label.
Source ID
H51-CFDA646729720763323818B4
- Serious or fatal respiratory failure.
- Coverage path
- structured_local_snapshot
Source ID
H51-C9E5A07237964390AA404864 - Coverage path label
- Structured GlobalRPh route snapshot
Source ID
H51-2939CC09A5F3D2988D122DFD - Official label url
- https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3a35b86c-f451-4fac-8499-43019e4da354 (opens in a new tab)
Source ID
H51-184E06E28E2CDBB3B15CA70C - Review note
- First-look orientation only. Verify indication, patient population, weight basis, organ function, exact IV product, dose, concentration, compatibility, rate, and current labeling before use.
Source ID
H51-41F0D5341A5CE79D9F11AAF6 - Search text
- Terlipressin Cardiovascular and vasoactive Vasopressin analog Hepatorenal syndrome with rapid reduction in kidney function in adults A vasopressin analog whose active metabolites predominantly stimulate V1 receptors and cause vasoconstriction. Adult | Existing preparation record; use current package insert for indication-specific selection | Label dose schedule adjusted by serum creatinine response | Not normalized in the preparation record | See current package insert and professional guidance | IV infusion; Adult | Label-scheduled dose | Label-scheduled dose | Patient- and indication-specific | See current package insert | IV push Slow IV bolus over approximately 2 minutes; Over about 2 minutes; Reconstituted product concentration; Over about 2 minutes The existing monograph contains a renal or nephrotoxicity signal; verify exact adjustment and monitoring in the current label. Serious or fatal respiratory failure. Ischemic events and contraindication in hypoxia or worsening respiratory symptoms. Avoid in patients unlikely to benefit such as very high creatinine or ACLF grade 3 per label. Structured GlobalRPh route snapshot TERLIVAZ TERLIVAZ (terlipressin) injection, powder, lyophilized, for solution DailyMed label snapshot dosage administration dosage forms strengths mechanism
Source ID
H51-AC0148A09AFF64E357867DB8 - Official search url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Terlipressin (opens in a new tab)
Source ID
H51-99CE5761D3ED6DE4CFB3E635 - Official access mode
- direct_label
Source ID
H51-AF47710E784F102171E5FD6E - Official access url
- https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3a35b86c-f451-4fac-8499-43019e4da354 (opens in a new tab)
Source ID
H51-0A362BCF89CD3BDCAAE0DFAD - Official search query
- Terlipressin
Source ID
H51-2962665036D07B11144B2FE3 - Official access reason
- Very-high-confidence exact IV product label selected during the v5.1 build-time review. Open the current full DailyMed monograph and verify the stocked product before use.
Source ID
H51-65D81CEA743DB1A9C872EE2C - Label snapshot available
- true
Source ID
H51-ECC2D93154784AEA1678B9C6 - Label snapshot setid
- 3a35b86c-f451-4fac-8499-43019e4da354
Source ID
H51-B3B5F6560969EEA9E776F345
Product identifiers and clinical review status
This monograph will be updated in the future. Historical material is available where present in the original sources; full current exact-product and claim-level review remains pending.
Exact formulation, concentration, container, manufacturer, regulatory identifiers, and a reproducible label snapshot have not all been reconciled.
What remains to be completed
- A retrieved source document is available; clinical reconciliation and a second-source claim map remain incomplete
- Clinically reviewed, individually identified statements with two exact source mappings
- Exact formulation, strength, container, manufacturer/labeler, application and NDC reconciliation
- Renal-function methods and dialysis/CRRT modality review where applicable
- Mechanism provenance, clinical source disagreements and full medication-specific safety reconciliation
Supplemental historical fields
Restored-data provenance and review notes
Source release: 2026-08-31. Current clinical review is incomplete. Original uses of current, verified, or normalized describe the historical source. They do not inherit the status of separately reviewed statements. Product formulations and source dates can differ.
Current review annotations for historical renal, dialysis, mechanism, and product fields
Separate renal reference: Open Renal Dosing Master (opens in a new tab)- Renal
- Status
- not_locally_normalized
- Original classification
- renal_review_flagged
- Entries
- General note
- Preserve the source-specific renal-function basis. An indexed CrCl table is not interchangeable with unindexed CrCl or eGFR. Generic advice to check a method does not identify the equation for a dose row.
- Dialysis
- Status
- no_local_structured_regimen
- Entries
- General note
- Named modality alone does not establish applicability. CRRT subtype, effluent rate, residual renal function, timing and interruptions require review. Historical absence is not evidence that no guidance exists.
- Mechanisms
- Source kind
- first_look
- Local pointer
- /mechanism
- Original level
- drug_specific
- Provenance classification
- historical_drug_specific_uncorroborated
- Label derived verified
- false
- Independently corroborated
- false
- Exact label section
- Not recorded
- Original source note
- Not recorded
- Review status
- historical_unverified
- Note
- Drug-specific wording in the old file is not proof of independent corroboration or an exact label locator. Consult separately published current mechanism claims where present.
- Source kind
- label_snapshot
- Local pointer
- /mechanism_summary
- Original level
- drug_specific
- Provenance classification
- historical_drug_specific_uncorroborated
- Label derived verified
- false
- Independently corroborated
- false
- Exact label section
- Not recorded
- Original source note
- Concise GlobalRPh summary reviewed against the selected DailyMed label clinical-pharmacology or microbiology content.
- Review status
- historical_unverified
- Note
- Drug-specific wording in the old file is not proof of independent corroboration or an exact label locator. Consult separately published current mechanism claims where present.
- Future update
- Status
- pending_review
- Message
- This monograph will be updated in the future as current exact-product and claim-level review is completed.
- Source unavailable
- false
- Reason
- The historical content is restored; comprehensive contemporary verification remains incomplete.
No separate structured rows were bundled for continuous infusion, dialysis, CRRT. Historical article content and source links may cover these topics.
Historical dilution and intermittent infusion preparation
Recovered v5.1 source content; historical, awaiting current review.
Separate renal reference: Open Renal Dosing Master (opens in a new tab)| Population | Amount | Reconstitution | Diluent | Final volume | Concentration | Rate | Stability | Notes |
|---|---|---|---|---|---|---|---|---|
Source IDH51-229063D8B097C5E0893DB3B2Source IDH51-0D9A730A38CE86029788E842 | Label dose schedule adjusted by serum creatinine responseSource IDH51-2922BF2BADBE3FF4F9590A78 | Reconstitute vial with 5 mL NS to the label concentration.Source IDH51-ADB055CBCFDF2AD0AC0ED117 | May administer reconstituted solution without further dilutionSource IDH51-AE30F11BE868C67877CF7C32 | 5 mL syringeSource IDH51-FA1DBA2384BFCF53D9328359 | Product-specificSource IDH51-5C0034CE0A30CEDDB6456025 | Slow IV bolus over approximately 2 minutesSource IDH51-5F157FCEC9BC8DBB87CB94C5 | Use the shorter of current product labeling, validated stability data, and the applicable USP <797> sterility-based BUD ceiling.Source IDH51-933B7DDC95E43A7133ABF8FC | Assess oxygenation and volume status before each dose and follow label stopping rules.Source IDH51-6A2B8C2C9074242DD7B3D788 |
Historical DailyMed label snapshot
Recovered v5.1 source content; historical, awaiting current review.
- Id
- terlipressin
Source ID
H51-7D2E490820852A1AEDC481A5 - Catalog name
- Terlipressin
Source ID
H51-69870DDCF06C1F7C58FD648B - Selection status
- accepted_high_confidence
Source ID
H51-000E6142D7EFBAF1602EC9C8 - Confidence
- very_high
Source ID
H51-DE82D2A93D138C167982D6CB - Match path
- search_to_exact_label
Source ID
H51-EF72C702D48B3F1D623E65B7 - Brand name
- TERLIVAZ
Source ID
H51-0CC5676E5724125A9317B0A4 - Label title
- TERLIVAZ (terlipressin) injection, powder, lyophilized, for solution
Source ID
H51-3DA5FB028297A0C3BCBAE5F4 - Setid
- 3a35b86c-f451-4fac-8499-43019e4da354
Source ID
H51-56D048CCDDE55F2476EB1B59 - Route
- Intermittent slow intravenous bolus
Source ID
H51-F290FF69B1110D52B6F0591A - Dosage form
- Lyophilized powder for reconstitution
Source ID
H51-83AE3DF405CCFDD58880EA99 - Dosage administration summary
- Administer 0.85 mg intravenously every 6 hours on days 1 through 3, then use the day-4 serum-creatinine response algorithm to continue, increase, or discontinue therapy.
Source ID
H51-FD1307EFC1EB13507884104B - Administer as a slow intravenous bolus over approximately 2 minutes and flush the line afterward.
Source ID
H51-3D0CFDECEC5A112302C9F85E - Do not exceed the label-defined treatment duration. Review respiratory-failure risk, oxygenation requirements, ischemic events, and transplant-priority implications.
Source ID
H51-FED0087404B8FF3EEC2758F3
- Administer 0.85 mg intravenously every 6 hours on days 1 through 3, then use the day-4 serum-creatinine response algorithm to continue, increase, or discontinue therapy.
- Dosage forms strengths
- 0.85 mg terlipressin lyophilized powder in a single-dose vial
Source ID
H51-A49896B4748344002D157C15
- 0.85 mg terlipressin lyophilized powder in a single-dose vial
- Mechanism summary
- Terlipressin is a vasopressin analog that produces predominantly V1-receptor-mediated vasoconstriction, increasing effective arterial volume in hepatorenal syndrome.
Source ID
H51-2D254EED68F9720C641F1504 - Scope note
- Selected TERLIVAZ label for adults with hepatorenal syndrome and rapidly worsening renal function.
Source ID
H51-F912C7B98E33C7CD82F055DE - Official label url
- https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3a35b86c-f451-4fac-8499-43019e4da354 (opens in a new tab)
Source ID
H51-F2A000B91C44A8AA8A3822F0 - Reviewed on
- 2026-08-31
Source ID
H51-1E446D08768C818B7A1AD682 - Mechanism source
- Concise GlobalRPh summary reviewed against the selected DailyMed label clinical-pharmacology or microbiology content.
Source ID
H51-040BF8FB361782AAE3C5C515 - Source sections
- Dosage and Administration
Source ID
H51-BB36E4EA50449354E2E6FBF7 - Dosage Forms and Strengths
Source ID
H51-469FE17D281AF838B3ED6FA9 - Clinical Pharmacology or Microbiology as applicable
Source ID
H51-1B974A013BEF985A89A4072A
- Dosage and Administration
- Retrieval method
- Manual build-time review of the current DailyMed full prescribing information for the selected Set ID; no live server retrieval is required during page use.
Source ID
H51-53F728123809F063272AFEF9 - Label status
- current
Source ID
H51-27B6F8B9FD75C4A32A2BB5DC - Disclaimer
- Verify the exact formulation, strength, manufacturer, NDC, route, current label revision, patient-specific order, institutional policy, and monitoring before use.
Source ID
H51-0500052B912ECE44800A7E0D
Historical IV-push guidance
Recovered v5.1 source content; historical, awaiting current review.
| Population | Dose scope | Concentration | Rate | Status |
|---|---|---|---|---|
Source IDH51-2361F9D8E80BEF974FB803CCSource IDH51-3A6B2D3DB5CC7388CE08AF19 | Label-scheduled doseSource IDH51-27A3AF150D798FE8EBCA5CEE | Reconstituted product concentrationSource IDH51-97BEB9D6BF8EF212EAD4ECEF | Over about 2 minutesSource IDH51-3EBBFAD73B3A79ECE0557D2E | Label-standard with strict eligibility and monitoringSource IDH51-92B210AB4E9723536202E48B |
Historical indication and population dosing
Recovered tables and source-separated snapshots; full clinical revalidation remains pending.
Existing dose and route snapshots
Separate renal reference: Open Renal Dosing Master (opens in a new tab)| Route | Population | Indication | Dose | Interval | Duration | Administration | Source level | Notes |
|---|---|---|---|---|---|---|---|---|
Source IDH51-B3FE34F9EFBB3E2225DB2BCBSource IDH51-B0E82FAD0807C522103F291E | AdultSource IDH51-7C5954D85ACBD14EE38DC4C6 | Existing preparation record; use current package insert for indication-specific selectionSource IDH51-4FB709921A43D69E37FE4D30 | Label dose schedule adjusted by serum creatinine responseSource IDH51-4189DBC847C08A1DD75D20B0 | Not normalized in the preparation recordSource IDH51-42974E81C00730664B09737C | See current package insert and professional guidanceSource IDH51-465E03EEAC62F34219795A26 | Slow IV bolus over approximately 2 minutesSource IDH51-4E0F7828A7A73BC9A4456250 | Existing GlobalRPh structured preparation snapshotSource IDH51-3064A25BEAAF0F080077B2C7 | Assess oxygenation and volume status before each dose and follow label stopping rules.Source IDH51-EBA9CFDDAEEE93CBE9189240 |
Source IDH51-D833443F368C3865FD8902E2Source IDH51-A60137441007F9F78FB60A35 | AdultSource IDH51-ECF321C74D1B131CFFB066A3 | Label-scheduled doseSource IDH51-1FD81C1B8F93A947D90FF694 | Label-scheduled doseSource IDH51-02A09A59C1D1E23495FA32B1 | Patient- and indication-specificSource IDH51-D34E074DC64CD8923DC35F6C | See current package insertSource IDH51-04D9A07F55D08A7B16319739 | Over about 2 minutesSource IDH51-F24C1937000163753745CBFB | Existing GlobalRPh IV push snapshotSource IDH51-DECE9A6160E96A3D2461695A | Label-standard with strict eligibility and monitoringSource IDH51-0B7F5BD34887A62B3CC699F8 |
Historical renal-function guidance
Recovered v5.1 source content; historical, awaiting current review.
Separate renal reference: Open Renal Dosing Master (opens in a new tab)- Classification
- renal_review_flagged
Source ID
H51-18297F0258F5B4753A5A9512 - Summary
- The existing monograph contains a renal or nephrotoxicity signal; verify exact adjustment and monitoring in the current label.
Source ID
H51-12F62F8DDC994831F4ED12BD - Method note
- Use the renal function estimate and body-size convention specified by the selected label or institutional protocol. Do not interchange Cockcroft-Gault CrCl, indexed eGFR, and de-indexed eGFR without confirming the dosing source.
Source ID
H51-DEBA4F0B6690B404FDA6EC9A
Historical Common IV uses
Recovered v5.1 source content; historical, awaiting current review.
Separate renal reference: Open Renal Dosing Master (opens in a new tab)- Hepatorenal syndrome with rapid reduction in kidney function in adults
Source ID
H51-739366599767462F076A8510
Historical Warnings and safeguards
Recovered v5.1 source content; historical, awaiting current review.
- Serious or fatal respiratory failure.
Source ID
H51-1B28AD6FBF9A025B181B4730 - Ischemic events and contraindication in hypoxia or worsening respiratory symptoms.
Source ID
H51-CF74D9A71715BA9B2888185C - Avoid in patients unlikely to benefit such as very high creatinine or ACLF grade 3 per label.
Source ID
H51-29A5EA1F26FB7BAAD7F10501
Historical Monitoring
Recovered v5.1 source content; historical, awaiting current review.
Separate renal reference: Open Renal Dosing Master (opens in a new tab)- Continuous or frequent oxygen saturation
Source ID
H51-823EB5955443A735E3DE9E0A - Respiratory status and volume overload
Source ID
H51-50D932589A65AC8FAEDC871B - Serum creatinine and ischemic symptoms
Source ID
H51-433B08DF3F99A4368DF146BA
Other recovered source fields and original editorial metadata
Original status words such as current, verified, or normalized describe the historical source release. They do not change the clinical review status of this release.
Catalog source fields
Id
terlipressinSource ID
H51-F5C2C328BA8427D4D869AA5BGeneric name
TerlipressinSource ID
H51-DF6B95A28B5A556F2EAB762ABrand names
- Terlivaz
Source ID
H51-E6BDAFA02DD0F745776E3458
Class
Cardiovascular and vasoactiveSource ID
H51-6235AFCA2D2185496AEB627FSubclass
Vasopressin analogSource ID
H51-152769C3B6819B1DD6AD2CCESummary
Vasopressin analog administered by scheduled IV bolus for hepatorenal syndrome; respiratory failure and ischemia are major safety concerns.Source ID
H51-8FA4C7D62CB3C7FC9DA36FA4Populations
- Adult
Source ID
H51-F20DD84146D6B0DCB7675FC0
Evidence tier
Core reference - verify current labelSource ID
H51-41C6EEC69564EF200C0ED184High alert
trueSource ID
H51-A0C9E849A282AEC28DA97642Hazardous
falseSource ID
H51-7CC40E230725D1105436AADAStatus
ActiveSource ID
H51-9B392D5171BF1E23CE6F6F1BReviewed
2026-08-29Source ID
H51-79DA5E1919DF81A0549A6342Version added
1.2Source ID
H51-CFA6700295C521332BC56731Sources
| Label | Url | Kind |
|---|---|---|
Source IDH51-26641056759B08A3F9A39CEDSource IDH51-CB722F3229E48D2B4F503C45 | https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Terlipressin (opens in a new tab)Source IDH51-1608BAC1A2278B5341EA96D2 | PrimarySource IDH51-213A8A49E1DF45C61F3037B1 |
Source IDH51-85714481656C9C7635D599B1Source IDH51-D22C128343ECB630394B5A64 | legacy:autoSource IDH51-4F852F33DA625A9F81F94E30 | LegacySource IDH51-CEB870F5ED70B05884DAF6E4 |
Clinical release verification
- Audit version
- 3.4
Source ID
H51-EEC717B196D41C4F6DA7DA4E - Audited on
- 2026-08-30
Source ID
H51-BC2C0746E4ECFF839A0A5E0C - Level
- amber
Source ID
H51-617CA40CA5E044A909497621 - Release gate
- trusted_professional_source_present_exact_label_unconfirmed
Source ID
H51-DF91ACCA2A4DB1042211281F - Exact current label candidate
- false
Source ID
H51-40ECDEB4EB8493A632E13808 - Numeric support ratio
- 0
Source ID
H51-0A9AE7D7EA4CF5E2C92DC759 - Reference url count
- 1
Source ID
H51-E26CEC529974DA47C0FF702A - Broken reference count
- 0
Source ID
H51-C3844C13EF6383C9589430B6 - Point of use confirmation required
- true
Source ID
H51-F479B4E88CEA988335AF5209 - Note
- Do not treat this record as a fully current product-specific monograph until the exact IV formulation and current sources are confirmed.
Source ID
H51-2D23D39E6147C13F105B3219 - Dailymed search url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Terlipressin (opens in a new tab)
Source ID
H51-5AF9BAD98841A96D95A2B3CB
Version updated
5.1Source ID
H51-C96FAD644B7AF82694A48CDFDosing source fields
Id
terlipressinSource ID
H51-B472F5AE8DBEE3885B866340Generic name
TerlipressinSource ID
H51-3174178CE1BF020E1AA6DEAECoverage status
direct_official_label_access_plus_local_snapshotSource ID
H51-A030D4F5649AD13953691655Package insert
- Query name
- Terlipressin
Source ID
H51-29C236762DC4909C0A332CDD - Product and route must match
- true
Source ID
H51-4E32B97EE59F64F520109184 - Live current label enabled
- false
Source ID
H51-373F3B9E0F47F28FA318ECCD - Source priority
- Reviewed local summary when available, then a verified DailyMed label or product search when available, followed by professional references and institutional policy.
Source ID
H51-5D3E442FBFF94F42726BD683 - Direct official label access enabled
- true
Source ID
H51-1B28E2152ECE2FC8CD0A4CD5 - Outbound server request required
- false
Source ID
H51-DE8396C517A4E9BD2CA45A31 - Local summary status
- not_bundled
Source ID
H51-5297E6BB324BC59FD3B5D415
Clinical review
- Locally normalized
- false
Source ID
H51-C946CFA08AEEA63E20EF2194 - Reviewed
- 2026-08-29
Source ID
H51-0EED77D13BD5918F3C6E8EE3 - Status
- Direct official package-insert access enabled; indication-specific local normalization pending.
Source ID
H51-D92B0CBB0506ECF4E84591F5
Clinical release verification
- Audit version
- 3.4
Source ID
H51-30DB2EA0DCD54436058776ED - Audited on
- 2026-08-30
Source ID
H51-8ADC375FBC42B623B494FB3A - Level
- amber
Source ID
H51-DAFEB1DD1DEFD84E6E746741 - Release gate
- trusted_professional_source_present_exact_label_unconfirmed
Source ID
H51-4035A5B60D5B555B09999A0F - Exact current label candidate
- false
Source ID
H51-F2C85E442635D41891DBA803 - Numeric support ratio
- 0
Source ID
H51-BD22B8DABAE65F259BA04DC1 - Reference url count
- 1
Source ID
H51-2DB38C7A7571BEDA84C9919F - Broken reference count
- 0
Source ID
H51-A310F1D751EA0B5E0FCB2709 - Point of use confirmation required
- true
Source ID
H51-2B6E55DFE1C16820B53A2EAA - Note
- Do not treat this record as a fully current product-specific monograph until the exact IV formulation and current sources are confirmed.
Source ID
H51-39A119F19F88F5FA5E85832C - Dailymed search url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Terlipressin (opens in a new tab)
Source ID
H51-CBC6D214B77C77B9721395B3
Historical preparation assessment
Recovered v5.1 source content; historical, awaiting current review.
- Id
- terlipressin
Source ID
H51-521FFA1FC641FB2885C313D7 - Name
- Terlipressin
Source ID
H51-FA9FFAD980BF4C581A5CEFC5 - Brands
- Terlivaz
Source ID
H51-B8CD722D4286949BD7F1E1B2 - Therapeutic class
- Cardiovascular and vasoactive
Source ID
H51-4E0EC38A20F4B4ED28B986B0 - Review version
- 3.1
Source ID
H51-FE12D86FE74B502097DD3965 - Review date
- 2026-08-30
Source ID
H51-0B714040E45E1CB68B27FD65 - Release status
- structured_record_current_label_not_confirmed
Source ID
H51-4969DFD01960ED125C107BD6 - Market status
- Status
- no_current_us_iv_spl_confirmed
Source ID
H51-F30BD2257CA79F8F9DBC490D - Basis
- No high-confidence current IV SPL was automatically selected; legacy information is segregated
Source ID
H51-8E2B4F29820671858C0EF3FA
- Ten point assessment
- Exact formulation
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-3EBDAD452E154E564B606306 - Reconstitution concentration
- Reconstitute vial with 5 mL NS to the label concentration.
Source ID
H51-CB0AB9181596EC073E779CD2 - Maximum or recommended final concentration
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-6EB20FB3AC851AFD5F5F97DB - Appropriate standardized containers
- 5 mL syringe
Source ID
H51-FFA0319C14291C3D819E2D78 - Adult dosing range
- Separate renal reference: Open Renal Dosing Master (opens in a new tab)Label dose schedule adjusted by serum creatinine response Label-scheduled dose Label-scheduled dose
Source ID
H51-137A1FAE0F3A9A0780EE0D45 - Pediatric dosing range
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-408ED9C0FCD2BD9FA9E50B5F - Neonatal dosing range
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-6D43B7B9132079A3BFC6911C - Infusion time
- Slow IV bolus over approximately 2 minutes Over about 2 minutes
Source ID
H51-671EF913F6BD76E2E411F530 - Fluid restriction alternatives
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-CC6B53DB788A4F5493A0AABE - Current manufacturer labeling
- Match confidence
- unresolved
Source ID
H51-C4C5B0678A75EFCFA9F054E8 - Url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Terlipressin (opens in a new tab)
Source ID
H51-1B3F03DB09160BB8956926D8
- Field provenance
- Exact formulation
- Primary
- not_found
Source ID
H51-FBBD6670159C0100187153DE
- Reconstitution concentration
- Primary
- existing_structured_record
Source ID
H51-921BE839C085C826C24F0BB7
- Maximum or recommended final concentration
- Primary
- not_found
Source ID
H51-AED8B5C249DE6FB4B0BF6B81
- Appropriate standardized containers
- Primary
- existing_structured_record
Source ID
H51-7ACAD0744B4FB9DA0229B5FD
- Adult dosing range
- Primary
- existing_structured_record
Source ID
H51-D02299349183398BEE686715
- Pediatric dosing range
- Primary
- not_found
Source ID
H51-3188EAB3D822962C717FF754
- Neonatal dosing range
- Primary
- not_found
Source ID
H51-BFA95F75D626275642909C17
- Infusion time
- Primary
- existing_structured_record
Source ID
H51-A647F18C253B6A3022AA84CB
- Fluid restriction alternatives
- Primary
- not_found
Source ID
H51-A4AC99F78B75281F97921BD7
- Current manufacturer labeling
- Primary
- DailyMed search gateway
Source ID
H51-82D3FE89DA1C50F518AB05B7
- Population applicability
- Adult
- Applicability
- supported_or_source_present
Source ID
H51-4DB1C3E9D243378BAEDCD271 - Guide generation allowed
- true
Source ID
H51-5FC94C073414C9B027E03D51
- Pediatric
- Applicability
- not_established
Source ID
H51-26BAD9B9F7D2019EA5902998 - Guide generation allowed
- false
Source ID
H51-43CE4E78AA72C314B1F89A86
- Neonatal
- Applicability
- not_established
Source ID
H51-B665342AA18125492C9C7860 - Guide generation allowed
- false
Source ID
H51-0D6082EBEA872218352AD274
- Route presence
- Structured dilution
- true
Source ID
H51-A183FF94D9BC691FAF949FDC - Iv push
- true
Source ID
H51-7874B1EB89C71E5499E65247 - Continuous infusion
- false
Source ID
H51-B0D6C9265C217AF6DDB0EC3D - Pediatric source
- false
Source ID
H51-B5263BB8435525BBB27C3F94 - Neonatal source
- false
Source ID
H51-CE39D78E468C4ACEBC2993EC
- Legacy reference
- Status
- not_available
Source ID
H51-E6BDB7973411FD40A2CB1E01
- Label resolution
- Status
- build_environment_network_unavailable
Source ID
H51-9CFB861E161D0E52A56929A8
- Source files
- catalog.json
Source ID
H51-A7B9F25B98E44E9098632444 - dosing.json
Source ID
H51-251A4A4D00A1F457EA616D1A - new-in-v1.2.json
Source ID
H51-B98164D6EA73D73A8B9BDD83
- catalog.json
- Clinical release note
- Preparation instructions are released only at the evidence level shown. Legacy content remains visibly separate. Exact product, NDC, route, current labeling, and institutional policy must be confirmed.
Source ID
H51-D80FD82364E460CB7D2E797D
Historical statement IDs and source locations
These IDs identify recovered source units. They are not evidence-qualified clinical claims.
| Historical ID | Original source location | Status |
|---|---|---|
H51-F5C2C328BA8427D4D869AA5B | catalog.json/records/235/id | Historical; current review incomplete |
H51-DF6B95A28B5A556F2EAB762A | catalog.json/records/235/generic_name | Historical; current review incomplete |
H51-E6BDAFA02DD0F745776E3458 | catalog.json/records/235/brand_names/0 | Historical; current review incomplete |
H51-6235AFCA2D2185496AEB627F | catalog.json/records/235/class | Historical; current review incomplete |
H51-152769C3B6819B1DD6AD2CCE | catalog.json/records/235/subclass | Historical; current review incomplete |
H51-8FA4C7D62CB3C7FC9DA36FA4 | catalog.json/records/235/summary | Historical; current review incomplete |
H51-739366599767462F076A8510 | catalog.json/records/235/common_uses/0 | Historical; current review incomplete |
H51-229063D8B097C5E0893DB3B2 | catalog.json/records/235/preparations/0 | Historical; current review incomplete |
H51-0D9A730A38CE86029788E842 | catalog.json/records/235/preparations/0/population | Historical; current review incomplete |
H51-2922BF2BADBE3FF4F9590A78 | catalog.json/records/235/preparations/0/amount | Historical; current review incomplete |
H51-ADB055CBCFDF2AD0AC0ED117 | catalog.json/records/235/preparations/0/reconstitution | Historical; current review incomplete |
H51-AE30F11BE868C67877CF7C32 | catalog.json/records/235/preparations/0/diluent | Historical; current review incomplete |
H51-FA1DBA2384BFCF53D9328359 | catalog.json/records/235/preparations/0/final_volume | Historical; current review incomplete |
H51-5C0034CE0A30CEDDB6456025 | catalog.json/records/235/preparations/0/concentration | Historical; current review incomplete |
H51-5F157FCEC9BC8DBB87CB94C5 | catalog.json/records/235/preparations/0/rate | Historical; current review incomplete |
H51-933B7DDC95E43A7133ABF8FC | catalog.json/records/235/preparations/0/stability | Historical; current review incomplete |
H51-6A2B8C2C9074242DD7B3D788 | catalog.json/records/235/preparations/0/notes | Historical; current review incomplete |
H51-2361F9D8E80BEF974FB803CC | catalog.json/records/235/iv_push/0 | Historical; current review incomplete |
H51-3A6B2D3DB5CC7388CE08AF19 | catalog.json/records/235/iv_push/0/population | Historical; current review incomplete |
H51-27A3AF150D798FE8EBCA5CEE | catalog.json/records/235/iv_push/0/dose_scope | Historical; current review incomplete |
H51-97BEB9D6BF8EF212EAD4ECEF | catalog.json/records/235/iv_push/0/concentration | Historical; current review incomplete |
H51-3EBBFAD73B3A79ECE0557D2E | catalog.json/records/235/iv_push/0/rate | Historical; current review incomplete |
H51-92B210AB4E9723536202E48B | catalog.json/records/235/iv_push/0/status | Historical; current review incomplete |
H51-241FADD099C9A6D9952ED922 | catalog.json/records/235/iv_push/0/notes | Historical; current review incomplete |
H51-1B28AD6FBF9A025B181B4730 | catalog.json/records/235/warnings/0 | Historical; current review incomplete |
H51-CF74D9A71715BA9B2888185C | catalog.json/records/235/warnings/1 | Historical; current review incomplete |
H51-29A5EA1F26FB7BAAD7F10501 | catalog.json/records/235/warnings/2 | Historical; current review incomplete |
H51-823EB5955443A735E3DE9E0A | catalog.json/records/235/monitoring/0 | Historical; current review incomplete |
H51-50D932589A65AC8FAEDC871B | catalog.json/records/235/monitoring/1 | Historical; current review incomplete |
H51-433B08DF3F99A4368DF146BA | catalog.json/records/235/monitoring/2 | Historical; current review incomplete |
H51-F20DD84146D6B0DCB7675FC0 | catalog.json/records/235/populations/0 | Historical; current review incomplete |
H51-41C6EEC69564EF200C0ED184 | catalog.json/records/235/evidence_tier | Historical; current review incomplete |
H51-A0C9E849A282AEC28DA97642 | catalog.json/records/235/high_alert | Historical; current review incomplete |
H51-7CC40E230725D1105436AADA | catalog.json/records/235/hazardous | Historical; current review incomplete |
H51-9B392D5171BF1E23CE6F6F1B | catalog.json/records/235/status | Historical; current review incomplete |
H51-79DA5E1919DF81A0549A6342 | catalog.json/records/235/reviewed | Historical; current review incomplete |
H51-CFA6700295C521332BC56731 | catalog.json/records/235/version_added | Historical; current review incomplete |
H51-26641056759B08A3F9A39CED | catalog.json/records/235/sources/0 | Historical; current review incomplete |
H51-CB722F3229E48D2B4F503C45 | catalog.json/records/235/sources/0/label | Historical; current review incomplete |
H51-1608BAC1A2278B5341EA96D2 | catalog.json/records/235/sources/0/url | Historical; current review incomplete |
H51-213A8A49E1DF45C61F3037B1 | catalog.json/records/235/sources/0/kind | Historical; current review incomplete |
H51-85714481656C9C7635D599B1 | catalog.json/records/235/sources/1 | Historical; current review incomplete |
H51-D22C128343ECB630394B5A64 | catalog.json/records/235/sources/1/label | Historical; current review incomplete |
H51-4F852F33DA625A9F81F94E30 | catalog.json/records/235/sources/1/url | Historical; current review incomplete |
H51-CEB870F5ED70B05884DAF6E4 | catalog.json/records/235/sources/1/kind | Historical; current review incomplete |
H51-46153F36CB5DA4BC7A8BFC30 | catalog.json/records/235/legacy_title | Historical; current review incomplete |
H51-EEC717B196D41C4F6DA7DA4E | catalog.json/records/235/clinical_release_verification/audit_version | Historical; current review incomplete |
H51-BC2C0746E4ECFF839A0A5E0C | catalog.json/records/235/clinical_release_verification/audited_on | Historical; current review incomplete |
H51-617CA40CA5E044A909497621 | catalog.json/records/235/clinical_release_verification/level | Historical; current review incomplete |
H51-DF91ACCA2A4DB1042211281F | catalog.json/records/235/clinical_release_verification/release_gate | Historical; current review incomplete |
H51-40ECDEB4EB8493A632E13808 | catalog.json/records/235/clinical_release_verification/exact_current_label_candidate | Historical; current review incomplete |
H51-FE10A1699D23E1E1F1C03DE8 | catalog.json/records/235/clinical_release_verification/selected_setid | Historical; current review incomplete |
H51-D4C4AA85172C7A00F3CD5D3F | catalog.json/records/235/clinical_release_verification/selected_label_title | Historical; current review incomplete |
H51-0A9AE7D7EA4CF5E2C92DC759 | catalog.json/records/235/clinical_release_verification/numeric_support_ratio | Historical; current review incomplete |
H51-E26CEC529974DA47C0FF702A | catalog.json/records/235/clinical_release_verification/reference_url_count | Historical; current review incomplete |
H51-C3844C13EF6383C9589430B6 | catalog.json/records/235/clinical_release_verification/broken_reference_count | Historical; current review incomplete |
H51-F479B4E88CEA988335AF5209 | catalog.json/records/235/clinical_release_verification/point_of_use_confirmation_required | Historical; current review incomplete |
H51-2D23D39E6147C13F105B3219 | catalog.json/records/235/clinical_release_verification/note | Historical; current review incomplete |
H51-5AF9BAD98841A96D95A2B3CB | catalog.json/records/235/clinical_release_verification/dailymed_search_url | Historical; current review incomplete |
H51-C96FAD644B7AF82694A48CDF | catalog.json/records/235/version_updated | Historical; current review incomplete |
H51-7D2E490820852A1AEDC481A5 | dailymed-label-snapshots-v5.1.json/records/46/id | Historical; current review incomplete |
H51-69870DDCF06C1F7C58FD648B | dailymed-label-snapshots-v5.1.json/records/46/catalog_name | Historical; current review incomplete |
H51-000E6142D7EFBAF1602EC9C8 | dailymed-label-snapshots-v5.1.json/records/46/selection_status | Historical; current review incomplete |
H51-DE82D2A93D138C167982D6CB | dailymed-label-snapshots-v5.1.json/records/46/confidence | Historical; current review incomplete |
H51-EF72C702D48B3F1D623E65B7 | dailymed-label-snapshots-v5.1.json/records/46/match_path | Historical; current review incomplete |
H51-0CC5676E5724125A9317B0A4 | dailymed-label-snapshots-v5.1.json/records/46/brand_name | Historical; current review incomplete |
H51-3DA5FB028297A0C3BCBAE5F4 | dailymed-label-snapshots-v5.1.json/records/46/label_title | Historical; current review incomplete |
H51-56D048CCDDE55F2476EB1B59 | dailymed-label-snapshots-v5.1.json/records/46/setid | Historical; current review incomplete |
H51-F290FF69B1110D52B6F0591A | dailymed-label-snapshots-v5.1.json/records/46/route | Historical; current review incomplete |
H51-83AE3DF405CCFDD58880EA99 | dailymed-label-snapshots-v5.1.json/records/46/dosage_form | Historical; current review incomplete |
H51-FD1307EFC1EB13507884104B | dailymed-label-snapshots-v5.1.json/records/46/dosage_administration_summary/0 | Historical; current review incomplete |
H51-3D0CFDECEC5A112302C9F85E | dailymed-label-snapshots-v5.1.json/records/46/dosage_administration_summary/1 | Historical; current review incomplete |
H51-FED0087404B8FF3EEC2758F3 | dailymed-label-snapshots-v5.1.json/records/46/dosage_administration_summary/2 | Historical; current review incomplete |
H51-A49896B4748344002D157C15 | dailymed-label-snapshots-v5.1.json/records/46/dosage_forms_strengths/0 | Historical; current review incomplete |
H51-2D254EED68F9720C641F1504 | dailymed-label-snapshots-v5.1.json/records/46/mechanism_summary | Historical; current review incomplete |
H51-F912C7B98E33C7CD82F055DE | dailymed-label-snapshots-v5.1.json/records/46/scope_note | Historical; current review incomplete |
H51-1FE2BDAB7394C18B2C22717D | dailymed-label-snapshots-v5.1.json/records/46/labeler | Historical; current review incomplete |
H51-F2A000B91C44A8AA8A3822F0 | dailymed-label-snapshots-v5.1.json/records/46/official_label_url | Historical; current review incomplete |
H51-1E446D08768C818B7A1AD682 | dailymed-label-snapshots-v5.1.json/records/46/reviewed_on | Historical; current review incomplete |
H51-040BF8FB361782AAE3C5C515 | dailymed-label-snapshots-v5.1.json/records/46/mechanism_source | Historical; current review incomplete |
H51-BB36E4EA50449354E2E6FBF7 | dailymed-label-snapshots-v5.1.json/records/46/source_sections/0 | Historical; current review incomplete |
H51-469FE17D281AF838B3ED6FA9 | dailymed-label-snapshots-v5.1.json/records/46/source_sections/1 | Historical; current review incomplete |
H51-1B974A013BEF985A89A4072A | dailymed-label-snapshots-v5.1.json/records/46/source_sections/2 | Historical; current review incomplete |
H51-53F728123809F063272AFEF9 | dailymed-label-snapshots-v5.1.json/records/46/retrieval_method | Historical; current review incomplete |
H51-27B6F8B9FD75C4A32A2BB5DC | dailymed-label-snapshots-v5.1.json/records/46/label_status | Historical; current review incomplete |
H51-0500052B912ECE44800A7E0D | dailymed-label-snapshots-v5.1.json/records/46/disclaimer | Historical; current review incomplete |
H51-B472F5AE8DBEE3885B866340 | dosing.json/records/235/id | Historical; current review incomplete |
H51-3174178CE1BF020E1AA6DEAE | dosing.json/records/235/generic_name | Historical; current review incomplete |
H51-A030D4F5649AD13953691655 | dosing.json/records/235/coverage_status | Historical; current review incomplete |
H51-29C236762DC4909C0A332CDD | dosing.json/records/235/package_insert/query_name | Historical; current review incomplete |
H51-B5D474908A6DAAB6A914F612 | dosing.json/records/235/package_insert/preferred_setid | Historical; current review incomplete |
H51-4E32B97EE59F64F520109184 | dosing.json/records/235/package_insert/product_and_route_must_match | Historical; current review incomplete |
H51-373F3B9E0F47F28FA318ECCD | dosing.json/records/235/package_insert/live_current_label_enabled | Historical; current review incomplete |
H51-5D3E442FBFF94F42726BD683 | dosing.json/records/235/package_insert/source_priority | Historical; current review incomplete |
H51-1B28E2152ECE2FC8CD0A4CD5 | dosing.json/records/235/package_insert/direct_official_label_access_enabled | Historical; current review incomplete |
H51-DE8396C517A4E9BD2CA45A31 | dosing.json/records/235/package_insert/outbound_server_request_required | Historical; current review incomplete |
H51-5297E6BB324BC59FD3B5D415 | dosing.json/records/235/package_insert/local_summary_status | Historical; current review incomplete |
H51-18297F0258F5B4753A5A9512 | dosing.json/records/235/renal/classification | Historical; current review incomplete |
H51-12F62F8DDC994831F4ED12BD | dosing.json/records/235/renal/summary | Historical; current review incomplete |
H51-DEBA4F0B6690B404FDA6EC9A | dosing.json/records/235/renal/method_note | Historical; current review incomplete |
H51-B3FE34F9EFBB3E2225DB2BCB | dosing.json/records/235/existing_route_snapshots/0 | Historical; current review incomplete |
H51-B0E82FAD0807C522103F291E | dosing.json/records/235/existing_route_snapshots/0/route | Historical; current review incomplete |
H51-7C5954D85ACBD14EE38DC4C6 | dosing.json/records/235/existing_route_snapshots/0/population | Historical; current review incomplete |
H51-4FB709921A43D69E37FE4D30 | dosing.json/records/235/existing_route_snapshots/0/indication | Historical; current review incomplete |
H51-4189DBC847C08A1DD75D20B0 | dosing.json/records/235/existing_route_snapshots/0/dose | Historical; current review incomplete |
H51-42974E81C00730664B09737C | dosing.json/records/235/existing_route_snapshots/0/interval | Historical; current review incomplete |
H51-465E03EEAC62F34219795A26 | dosing.json/records/235/existing_route_snapshots/0/duration | Historical; current review incomplete |
H51-4E0F7828A7A73BC9A4456250 | dosing.json/records/235/existing_route_snapshots/0/administration | Historical; current review incomplete |
H51-3064A25BEAAF0F080077B2C7 | dosing.json/records/235/existing_route_snapshots/0/source_level | Historical; current review incomplete |
H51-EBA9CFDDAEEE93CBE9189240 | dosing.json/records/235/existing_route_snapshots/0/notes | Historical; current review incomplete |
H51-D833443F368C3865FD8902E2 | dosing.json/records/235/existing_route_snapshots/1 | Historical; current review incomplete |
H51-A60137441007F9F78FB60A35 | dosing.json/records/235/existing_route_snapshots/1/route | Historical; current review incomplete |
H51-ECF321C74D1B131CFFB066A3 | dosing.json/records/235/existing_route_snapshots/1/population | Historical; current review incomplete |
H51-1FD81C1B8F93A947D90FF694 | dosing.json/records/235/existing_route_snapshots/1/indication | Historical; current review incomplete |
H51-02A09A59C1D1E23495FA32B1 | dosing.json/records/235/existing_route_snapshots/1/dose | Historical; current review incomplete |
H51-D34E074DC64CD8923DC35F6C | dosing.json/records/235/existing_route_snapshots/1/interval | Historical; current review incomplete |
H51-04D9A07F55D08A7B16319739 | dosing.json/records/235/existing_route_snapshots/1/duration | Historical; current review incomplete |
H51-F24C1937000163753745CBFB | dosing.json/records/235/existing_route_snapshots/1/administration | Historical; current review incomplete |
H51-DECE9A6160E96A3D2461695A | dosing.json/records/235/existing_route_snapshots/1/source_level | Historical; current review incomplete |
H51-0B7F5BD34887A62B3CC699F8 | dosing.json/records/235/existing_route_snapshots/1/notes | Historical; current review incomplete |
H51-C946CFA08AEEA63E20EF2194 | dosing.json/records/235/clinical_review/locally_normalized | Historical; current review incomplete |
H51-0EED77D13BD5918F3C6E8EE3 | dosing.json/records/235/clinical_review/reviewed | Historical; current review incomplete |
H51-D92B0CBB0506ECF4E84591F5 | dosing.json/records/235/clinical_review/status | Historical; current review incomplete |
H51-30DB2EA0DCD54436058776ED | dosing.json/records/235/clinical_release_verification/audit_version | Historical; current review incomplete |
H51-8ADC375FBC42B623B494FB3A | dosing.json/records/235/clinical_release_verification/audited_on | Historical; current review incomplete |
H51-DAFEB1DD1DEFD84E6E746741 | dosing.json/records/235/clinical_release_verification/level | Historical; current review incomplete |
H51-4035A5B60D5B555B09999A0F | dosing.json/records/235/clinical_release_verification/release_gate | Historical; current review incomplete |
H51-F2C85E442635D41891DBA803 | dosing.json/records/235/clinical_release_verification/exact_current_label_candidate | Historical; current review incomplete |
H51-80783FB5F2409EE59F38E6C8 | dosing.json/records/235/clinical_release_verification/selected_setid | Historical; current review incomplete |
H51-498DB9D40089997D5A1110FB | dosing.json/records/235/clinical_release_verification/selected_label_title | Historical; current review incomplete |
H51-BD22B8DABAE65F259BA04DC1 | dosing.json/records/235/clinical_release_verification/numeric_support_ratio | Historical; current review incomplete |
H51-2DB38C7A7571BEDA84C9919F | dosing.json/records/235/clinical_release_verification/reference_url_count | Historical; current review incomplete |
H51-A310F1D751EA0B5E0FCB2709 | dosing.json/records/235/clinical_release_verification/broken_reference_count | Historical; current review incomplete |
H51-2B6E55DFE1C16820B53A2EAA | dosing.json/records/235/clinical_release_verification/point_of_use_confirmation_required | Historical; current review incomplete |
H51-39A119F19F88F5FA5E85832C | dosing.json/records/235/clinical_release_verification/note | Historical; current review incomplete |
H51-CBC6D214B77C77B9721395B3 | dosing.json/records/235/clinical_release_verification/dailymed_search_url | Historical; current review incomplete |
H51-7684F288397EC9C36BDEACEA | first-look-v5.1.json/records/235/id | Historical; current review incomplete |
H51-66C278E93827A1FA89B48900 | first-look-v5.1.json/records/235/generic_name | Historical; current review incomplete |
H51-461C0D83C5131C1A0E26142E | first-look-v5.1.json/records/235/class | Historical; current review incomplete |
H51-4D8FBE049AF3764451503C4B | first-look-v5.1.json/records/235/subclass | Historical; current review incomplete |
H51-3FE119111CE53167235A913F | first-look-v5.1.json/records/235/primary_uses/0 | Historical; current review incomplete |
H51-89266BFF5D89195724B204C5 | first-look-v5.1.json/records/235/mechanism | Historical; current review incomplete |
H51-A8B083AF63A22B0557BA478E | first-look-v5.1.json/records/235/mechanism_level | Historical; current review incomplete |
H51-1D266D78DF3E7091E40A2CBE | first-look-v5.1.json/records/235/basic_dosing_orientation | Historical; current review incomplete |
H51-8CB966CC4CA97F32AB4155C9 | first-look-v5.1.json/records/235/administration_orientation | Historical; current review incomplete |
H51-2CD4DEF3A54D49DCB30189B0 | first-look-v5.1.json/records/235/renal_and_population_orientation | Historical; current review incomplete |
H51-4ECCD182972171DA1E36B519 | first-look-v5.1.json/records/235/key_safety_orientation/0 | Historical; current review incomplete |
H51-880F20825D569FA9CEF70712 | first-look-v5.1.json/records/235/key_safety_orientation/1 | Historical; current review incomplete |
H51-CFDA646729720763323818B4 | first-look-v5.1.json/records/235/key_safety_orientation/2 | Historical; current review incomplete |
H51-C9E5A07237964390AA404864 | first-look-v5.1.json/records/235/coverage_path | Historical; current review incomplete |
H51-2939CC09A5F3D2988D122DFD | first-look-v5.1.json/records/235/coverage_path_label | Historical; current review incomplete |
H51-184E06E28E2CDBB3B15CA70C | first-look-v5.1.json/records/235/official_label_url | Historical; current review incomplete |
H51-068225AF39152DF303446F04 | first-look-v5.1.json/records/235/legacy_title | Historical; current review incomplete |
H51-41F0D5341A5CE79D9F11AAF6 | first-look-v5.1.json/records/235/review_note | Historical; current review incomplete |
H51-AC0148A09AFF64E357867DB8 | first-look-v5.1.json/records/235/search_text | Historical; current review incomplete |
H51-99CE5761D3ED6DE4CFB3E635 | first-look-v5.1.json/records/235/official_search_url | Historical; current review incomplete |
H51-AF47710E784F102171E5FD6E | first-look-v5.1.json/records/235/official_access_mode | Historical; current review incomplete |
H51-0A362BCF89CD3BDCAAE0DFAD | first-look-v5.1.json/records/235/official_access_url | Historical; current review incomplete |
H51-2962665036D07B11144B2FE3 | first-look-v5.1.json/records/235/official_search_query | Historical; current review incomplete |
H51-65D81CEA743DB1A9C872EE2C | first-look-v5.1.json/records/235/official_access_reason | Historical; current review incomplete |
H51-ECC2D93154784AEA1678B9C6 | first-look-v5.1.json/records/235/label_snapshot_available | Historical; current review incomplete |
H51-B3B5F6560969EEA9E776F345 | first-look-v5.1.json/records/235/label_snapshot_setid | Historical; current review incomplete |
H51-521FFA1FC641FB2885C313D7 | preparation-assessments-v3.8.json/235/id | Historical; current review incomplete |
H51-FA9FFAD980BF4C581A5CEFC5 | preparation-assessments-v3.8.json/235/name | Historical; current review incomplete |
H51-B8CD722D4286949BD7F1E1B2 | preparation-assessments-v3.8.json/235/brands | Historical; current review incomplete |
H51-4E0EC38A20F4B4ED28B986B0 | preparation-assessments-v3.8.json/235/therapeutic_class | Historical; current review incomplete |
H51-FE12D86FE74B502097DD3965 | preparation-assessments-v3.8.json/235/review_version | Historical; current review incomplete |
H51-0B714040E45E1CB68B27FD65 | preparation-assessments-v3.8.json/235/review_date | Historical; current review incomplete |
H51-4969DFD01960ED125C107BD6 | preparation-assessments-v3.8.json/235/release_status | Historical; current review incomplete |
H51-F30BD2257CA79F8F9DBC490D | preparation-assessments-v3.8.json/235/market_status/status | Historical; current review incomplete |
H51-8E2B4F29820671858C0EF3FA | preparation-assessments-v3.8.json/235/market_status/basis | Historical; current review incomplete |
H51-3EBDAD452E154E564B606306 | preparation-assessments-v3.8.json/235/ten_point_assessment/exact_formulation | Historical; current review incomplete |
H51-CB0AB9181596EC073E779CD2 | preparation-assessments-v3.8.json/235/ten_point_assessment/reconstitution_concentration | Historical; current review incomplete |
H51-6EB20FB3AC851AFD5F5F97DB | preparation-assessments-v3.8.json/235/ten_point_assessment/maximum_or_recommended_final_concentration | Historical; current review incomplete |
H51-FFA0319C14291C3D819E2D78 | preparation-assessments-v3.8.json/235/ten_point_assessment/appropriate_standardized_containers | Historical; current review incomplete |
H51-137A1FAE0F3A9A0780EE0D45 | preparation-assessments-v3.8.json/235/ten_point_assessment/adult_dosing_range | Historical; current review incomplete |
H51-408ED9C0FCD2BD9FA9E50B5F | preparation-assessments-v3.8.json/235/ten_point_assessment/pediatric_dosing_range | Historical; current review incomplete |
H51-6D43B7B9132079A3BFC6911C | preparation-assessments-v3.8.json/235/ten_point_assessment/neonatal_dosing_range | Historical; current review incomplete |
H51-671EF913F6BD76E2E411F530 | preparation-assessments-v3.8.json/235/ten_point_assessment/infusion_time | Historical; current review incomplete |
H51-CC6B53DB788A4F5493A0AABE | preparation-assessments-v3.8.json/235/ten_point_assessment/fluid_restriction_alternatives | Historical; current review incomplete |
H51-17F1677D14AF5D6C7046E9AE | preparation-assessments-v3.8.json/235/ten_point_assessment/current_manufacturer_labeling/setid | Historical; current review incomplete |
H51-DA083CD332A0BDE1AE6BA1E2 | preparation-assessments-v3.8.json/235/ten_point_assessment/current_manufacturer_labeling/title | Historical; current review incomplete |
H51-A65B0099F4E2F752206E2937 | preparation-assessments-v3.8.json/235/ten_point_assessment/current_manufacturer_labeling/published_date | Historical; current review incomplete |
H51-D19B5B5152E21B1D19343BB4 | preparation-assessments-v3.8.json/235/ten_point_assessment/current_manufacturer_labeling/manufacturer | Historical; current review incomplete |
H51-C4C5B0678A75EFCFA9F054E8 | preparation-assessments-v3.8.json/235/ten_point_assessment/current_manufacturer_labeling/match_confidence | Historical; current review incomplete |
H51-1B3F03DB09160BB8956926D8 | preparation-assessments-v3.8.json/235/ten_point_assessment/current_manufacturer_labeling/url | Historical; current review incomplete |
H51-FBBD6670159C0100187153DE | preparation-assessments-v3.8.json/235/field_provenance/exact_formulation/primary | Historical; current review incomplete |
H51-921BE839C085C826C24F0BB7 | preparation-assessments-v3.8.json/235/field_provenance/reconstitution_concentration/primary | Historical; current review incomplete |
H51-AED8B5C249DE6FB4B0BF6B81 | preparation-assessments-v3.8.json/235/field_provenance/maximum_or_recommended_final_concentration/primary | Historical; current review incomplete |
H51-7ACAD0744B4FB9DA0229B5FD | preparation-assessments-v3.8.json/235/field_provenance/appropriate_standardized_containers/primary | Historical; current review incomplete |
H51-D02299349183398BEE686715 | preparation-assessments-v3.8.json/235/field_provenance/adult_dosing_range/primary | Historical; current review incomplete |
H51-3188EAB3D822962C717FF754 | preparation-assessments-v3.8.json/235/field_provenance/pediatric_dosing_range/primary | Historical; current review incomplete |
H51-BFA95F75D626275642909C17 | preparation-assessments-v3.8.json/235/field_provenance/neonatal_dosing_range/primary | Historical; current review incomplete |
H51-A647F18C253B6A3022AA84CB | preparation-assessments-v3.8.json/235/field_provenance/infusion_time/primary | Historical; current review incomplete |
H51-A4AC99F78B75281F97921BD7 | preparation-assessments-v3.8.json/235/field_provenance/fluid_restriction_alternatives/primary | Historical; current review incomplete |
H51-82D3FE89DA1C50F518AB05B7 | preparation-assessments-v3.8.json/235/field_provenance/current_manufacturer_labeling/primary | Historical; current review incomplete |
H51-4DB1C3E9D243378BAEDCD271 | preparation-assessments-v3.8.json/235/population_applicability/adult/applicability | Historical; current review incomplete |
H51-5FC94C073414C9B027E03D51 | preparation-assessments-v3.8.json/235/population_applicability/adult/guide_generation_allowed | Historical; current review incomplete |
H51-26BAD9B9F7D2019EA5902998 | preparation-assessments-v3.8.json/235/population_applicability/pediatric/applicability | Historical; current review incomplete |
H51-43CE4E78AA72C314B1F89A86 | preparation-assessments-v3.8.json/235/population_applicability/pediatric/guide_generation_allowed | Historical; current review incomplete |
H51-B665342AA18125492C9C7860 | preparation-assessments-v3.8.json/235/population_applicability/neonatal/applicability | Historical; current review incomplete |
H51-0D6082EBEA872218352AD274 | preparation-assessments-v3.8.json/235/population_applicability/neonatal/guide_generation_allowed | Historical; current review incomplete |
H51-A183FF94D9BC691FAF949FDC | preparation-assessments-v3.8.json/235/route_presence/structured_dilution | Historical; current review incomplete |
H51-7874B1EB89C71E5499E65247 | preparation-assessments-v3.8.json/235/route_presence/iv_push | Historical; current review incomplete |
H51-B0D6C9265C217AF6DDB0EC3D | preparation-assessments-v3.8.json/235/route_presence/continuous_infusion | Historical; current review incomplete |
H51-B5263BB8435525BBB27C3F94 | preparation-assessments-v3.8.json/235/route_presence/pediatric_source | Historical; current review incomplete |
H51-CE39D78E468C4ACEBC2993EC | preparation-assessments-v3.8.json/235/route_presence/neonatal_source | Historical; current review incomplete |
H51-E6BDB7973411FD40A2CB1E01 | preparation-assessments-v3.8.json/235/legacy_reference/status | Historical; current review incomplete |
H51-9CFB861E161D0E52A56929A8 | preparation-assessments-v3.8.json/235/label_resolution/status | Historical; current review incomplete |
H51-A7B9F25B98E44E9098632444 | preparation-assessments-v3.8.json/235/source_files/0 | Historical; current review incomplete |
H51-251A4A4D00A1F457EA616D1A | preparation-assessments-v3.8.json/235/source_files/1 | Historical; current review incomplete |
H51-B98164D6EA73D73A8B9BDD83 | preparation-assessments-v3.8.json/235/source_files/2 | Historical; current review incomplete |
H51-D80FD82364E460CB7D2E797D | preparation-assessments-v3.8.json/235/clinical_release_note | Historical; current review incomplete |